24-hour systemic antibiotic prophylaxis in large-bowel surgery

Area of Science:

• Surgical Oncology
• Infectious Diseases
• Clinical Pharmacology

Background:

• Colorectal surgery carries a significant risk of surgical site infections (SSIs).
• Effective prophylactic antibiotic strategies are crucial for improving patient outcomes.
• Optimizing antibiotic regimens can reduce SSI rates and associated morbidity.

Purpose of the Study:

• To evaluate the efficacy of a short prophylactic course of a specific antibiotic combination in preventing SSIs after elective colorectal surgery.
• To compare infection rates between patients receiving prophylactic antibiotics and a control group.

Main Methods:

• Prospective, randomized, double-blind trial involving 53 patients undergoing elective colorectal surgery.
• Patients received either conventional bowel preparation or an elementary diet.
• Treatment group received intramuscular kanamycin (500 mg) and clindamycin (600 mg) for 3 doses.
• Control group received no prophylactic antibiotics.

Main Results:

• Overall wound infection rates were 8% in the treatment group (25 patients) versus 66.7% in the control group (24 patients).
• Clinically important (grade II) wound infections occurred in 4.0% of the treatment group compared to 54.7% in the control group.
• The observed differences in infection rates were statistically significant (p < 0.0005).

Conclusions:

• A short prophylactic course of kanamycin and clindamycin significantly reduces the incidence of surgical site infections following elective colorectal surgery.
• This antibiotic regimen is highly effective in preventing both minor and clinically important wound infections.
• The findings support the use of this specific antibiotic combination as a prophylactic measure in colorectal surgery.